Gene Query: ADAM10

Dataset Description Geneva Score
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 74.48
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 56.05
RNA expression analysis upon JMJD1C depletion 41.12
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 41.12
RNA-seq analysis of BAP1-depleted uveal melanoma cells 39.6
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 38.09
hnRNP C is a key regulator of protein synthesis in mitosis 37.02
Survival of pancreatic cancer cells lacking KRAS function 33.66
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 30.63
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 30.6
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 29.64
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 27.98
Uridylation by TUT4 and TUT7 marks mRNA for degradation 26.33
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 26.21
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 25.26
Expression by CD133+ cells isolated from the adult human exocrine pancreas 25.17
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 23.14
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 23.13
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 23.13
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 22.56
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 22.31
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 22.29
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 22.11
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 21.61
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 21.27
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 21.1
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 21.04
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 19.5
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 18.91
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 18.91
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 18.71
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 18.28
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 18.27
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 18.11
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 18.11
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 17.64
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 17.44
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 17.44
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 17.43
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 17.16
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 17.16
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 17.13
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 17.11
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 16.83
Ribosomal footprinting of CN34-Parental and CN34-LM1a 16.53
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 16.42
RNA-seq of shEZH2 cells 16.4
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 16.3
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 16.13
Ribosomal footprinting of MDA-Parental and MDA-LM2 16.02
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 15.91
Regulation of highly expressed hCINAP on translatome 15.71
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 15.7
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 15.57
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 15.57
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 15.5
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 15.47
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 15.43
Novel Targeting of Transcription and Metabolism in Glioblastoma 15.41
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 15.4
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 15.4
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 15.37
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 15.31
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 15.1
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 14.96
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 14.95
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 14.92
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 14.51
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 14.51
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.42
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.42
Functional role of CPPED1 in trophoblasts. 14.35
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 14.28
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 14.03
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 14.02
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 13.94
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 13.91
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 13.9
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 13.7
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.65
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 13.5
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 13.49
Differetially expressed genes after hTR overexpression in U2OS cells 13.49
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 13.35
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 13.34
Global expression profiles in cardiac progenitor cells generated by ISX-9 13.34
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 13.31
METTL3 promotes translation in human cancer cells 13.29
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 13.14
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 13.08
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 12.96
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 12.81
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 12.78
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 12.77
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 12.73
A transcriptome dataset revealing the molecular features of breast cancer stem cells 12.67
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 12.38
ARS2 is a general suppressor of pervasive transcription [RNAseq] 12.37
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 11.97
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 11.96
Human cells contain natural double-stranded RNAs with potential regulatory capacity 11.94
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 11.91
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 11.88
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 11.72
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 11.66
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 11.46
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 11.32
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 11.27
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 11.23
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 11.22
Biological effect of chronic mistranslation in mammalian cells 11.21
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 11.05
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.01
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 11.0
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 10.93
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 10.93
K562 polyA RNA-Seq 10.85
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 10.81
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 10.81
Genome wide expression change by RNF168 knocking down in MCF-7 cells 10.8
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 10.74
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 10.7
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 10.63
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 10.59
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 10.59
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 10.5
hTERT promotes cell adhesion and migration independent of telomerase activity 10.47
BCL11B 10.33
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 10.31
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 10.28
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.27
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.21
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 10.09
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.08
NAPRT activation of macrophages 10.05
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 9.95
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.94
Differential gene expression of human melanoma cells [RNA-seq] 9.91
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 9.91
HNRNPL and its RNA Targets in Prostate Cancer 9.89
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 9.89
Identification of renal resident macrophages across species [C1] 9.8
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 9.79
LNCaP treated with iBET 9.78
Intron retention induced by microsatellite expansions as a disease biomarker. 9.77
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.74
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 9.73
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 9.7
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 9.64
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 9.63
Sensing self and nonself circular RNAs 9.63
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 9.6
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 9.6
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 9.57
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 9.57
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 9.57
RNA-seq analyses of human prostate cancer cells 9.55
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.51
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.51
RNA-seq melanoma 9.5
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.5
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 9.49
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 9.48
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 9.41
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 9.34
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 9.29
Induced DNA demethylation, genome instability and transcription 9.26
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 9.26
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 9.21
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 9.21
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.02
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.02
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 9.01
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 8.99
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 8.97
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 8.94
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.9
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.9
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.9
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.89
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 8.88
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 8.84
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 8.84
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 8.6
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 8.54
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 8.53
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 8.52
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 8.46
Nutritional control of protein translation 8.45
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.44
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.43
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 8.41
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 8.41
Exploring the RNA landscape of endothelial exosomes 8.39
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 8.34
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.33
Chromatin-informed inference of transcriptional programs in gynecologic cancers 8.32
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 8.32
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 8.3
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 8.27
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.24
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 8.24
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 8.2
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.16
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 8.14
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 8.1
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 8.1
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 8.06
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 8.0
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 8.0
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 7.99
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.99
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.91
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 7.78
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 7.78
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 7.73
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.72
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.7
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 7.69
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.69
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.69
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 7.68
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 7.67
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.67
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 7.62
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.6
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.55
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 7.51
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 7.28
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 7.27
Defective structural RNA processing in relapsing-remitting multiple sclerosis 7.21
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 7.13
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.09
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.09
The contribution of Alu exons to the human proteome 7.02
Effect of PBK knockdown on C4-2 cell transcriptome 6.97
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 6.89
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.85
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 6.82
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 6.82
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 6.79
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 6.73
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 6.72
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 6.72
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 6.72
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 6.72
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 6.71
Characterization of parental and rociletinib-resistant derived H1975 cell lines 6.66
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 6.43
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 6.39
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.38
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.38
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 6.38
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.26
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.2
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 6.06
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 6.02
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 6.02
The Genetic Landscape of Diamond-Blackfan Anemia 6.0
Role of microRNAs in the interaction between Salmonella and the host cell 6.0
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 5.96
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 5.88
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.81
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.81
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 5.8
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 5.78
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.77
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.71
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.71
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 5.67
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 5.67
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 5.67
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.63
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 5.61
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 5.57
AUF-1 affected genes in human skin cells 5.55
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 5.55
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.54
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 5.46
Unique features and clinical importance of acute alloreactive immune responses 5.43
Molecular Criteria for Defining the Naive Human Pluripotent State 5.39
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.39
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 5.38
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 5.32
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 5.28
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 5.28
STX4 Over-Expression in Human islets 5.27
Interaction between mitoNEET and NAF-1 in cancer cells 5.26
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.26
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 5.21
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 5.19
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 5.05
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.05
RNA-seq of RKO cells with cTAZ KO or putback 5.05
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.01
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.01
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 5.0
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 4.99
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.93
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.91
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 4.91
Copper Regulation of HIF-1 Transcription Activity 4.91
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 4.85
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.78
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 4.78
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.74
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.71
The transcriptome effect of overexpressing EZH2 in MCF7 4.7
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 4.69
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.63
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.59
RNA Sequencing of Human iPS derived Cardiomyocytes 4.54
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.53
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 4.52
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.52
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 4.5
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.49
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 4.49
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.46
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 4.45
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.43
Induction of Cardiomyocyte Proliferation [pz-822_human] 4.36
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 4.36
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.36
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.33
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.27
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 4.25
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 4.19
The cohesin release factor WAPL restricts chromatin loop extension. 4.15
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.15
Transcriptome of U251 cells overexpression complement component 7 4.09
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.09
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.09
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 4.06
Argonaute proteins couple chromatin silencing to alternative splicing 4.02
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 4.02
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.98
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 3.93
N6-methyladenine DNA Modification in Glioblastoma 3.92
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.92
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 3.81
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 3.81
Global response to chemotherapy-induced apoptosis 3.79
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.79
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.74
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.74
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.73
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.71
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.67
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.62
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.61
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.58
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.57
A novel target of EZH1/2 for treatment of mantle cell lymphoma 3.57
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 3.52
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 3.52
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 3.51
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.49
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.49
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 3.49
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 3.49
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 3.49
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.45
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.4
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.38
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.38
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 3.31
Regulatory network controlling tumor-promoting inflammation in human cancers 3.29
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.29
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.23
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.18
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.15
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 3.14
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 3.14
Identification of renal resident macrophages across species 3.09
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.07
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.05
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.04
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.02
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.95
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 2.93
IMP3 regulated gene expression in breast cancer cells 2.92
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.84
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.71
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.7
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 2.63
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.63
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 2.59
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 2.59
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 2.59
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.56
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.51
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.49
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.48
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.47
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.41
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.41
WNT signaling memory is required for ACTIVIN to function as a morphogen 2.34
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.31
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.25
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.24
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.19
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.19
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.18
Anti-inflammatory effect of indoleacrylic acid (IA) 2.17
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.11
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.11
Exploring ILF2 regulatory genes by next-generation sequencing 2.11
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.1
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.09
Ribosome profiling upon inhibition of eIF4A 2.07
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.06
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.03
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 2.03
Identification of global XBP1s target gene expression in human prostate cancer cells 2.02
naive T cell heterogeneity after neonatal thymectomy 2.02
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.01
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.01
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.97
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.97
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.92
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.9
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.85
ZIKV infection of monocytes activates inflammasome pathways 1.77
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.76
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.76
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.67
RNA-seq analysis of control and Myc-induced U2OS cells 1.65
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.64
CD73 knockdown effect in pancreatic cancer cell lines 1.62
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.56
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.5
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.49
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.46
Metastasis in triple-negative breast cancer 1.42
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.42
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.37
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.24
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.23
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.23
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 1.18
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.18
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.18
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.12
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.09
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.09
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.07
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.05
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.05
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.02
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.02
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.97
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.94
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.94
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.9
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.9
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.87
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.82
Gene expression profiling of KSHV-infected periodontal ligament cells 0.81
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.81
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.81
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.77
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.67
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.66
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.64
Transcriptome sequencing of K-562 cells 0.64
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.63
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.61
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.59
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 0.57
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.51
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.51
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.51
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.5
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.48
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.45
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 0.42
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 0.42
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.36
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.36
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.34
Effects of transcription on genome - nuclear lamina interactions 0.34
Expression analysis of the TAF1 syndrome 0.31
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 0.31
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.31
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.3
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.29
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.24
A code of mono-phosphorylation modulates the function of RB. 0.18
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.17
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.16
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.13
Transcriptome analysis of CNS leukemia 0.09
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.09
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.07
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.07
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.05
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.04
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation